SA
Therapeutic Areas
Combioxin Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CAL02 | Severe Community-Acquired Bacterial Pneumonia (SCAP/SCABP) | Phase 2b |
| Immunoparalysis Program | Acquired Immune Deficiency in Critically Ill Patients (e.g., Sepsis) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| CAL02 | Severe Community-Acquired Bacterial Pneumonia (SCAP/SCABP) | Phase 2b |
| Immunoparalysis Program | Acquired Immune Deficiency in Critically Ill Patients (e.g., Sepsis) | Pre-clinical |